What is the indicator(s) and accompanying M&E strategy that enables country programs to determine when the risk of ongoing transmission of LF has been reduced so that IDA can be stopped with little risk of resurgence of transmission?
Operational research to develop an M&E strategy to guide triple drug stopping decisions for lymphatic filariasis in Samoa
The xenomonitoring has been completed and the human sampling is presently ongoing.
Email primary contact
Please log in or register